Neurocrine Biosciences Provides Update on ERUDITE Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia - StockTitan
| NBIFIN Stock | 2,563 52.30 2.00% |
About 61% of N B's investor base is looking to short. The analysis of the overall prospects from investing in N B I suggests that many traders are, at the present time, alarmed. The current market sentiment, together with N B's historical and current headlines, can help investors time the market. In addition, many technical investors use N B I stock news signals to limit their universe of possible portfolio assets.
NBIFIN |
Neurocrine Biosciences Provides Update on ERUDITE Phase 2 Data for Luvadaxistat in Adults with Cognitive Impairment Associated with Schizophrenia StockTitan
Read at news.google.com
 |
N B Fundamental Analysis
We analyze N B's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of N B using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of N B based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
N B is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
N B I Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with N B stock to make a market-neutral strategy. Peer analysis of N B could also be used in its relative valuation, which is a method of valuing N B by comparing valuation metrics with similar companies.
Peers
N B Related Equities
| ALKALI | Alkali Metals | 0.55 | ||||
| UNIVAFOODS | Univa Foods | 0.00 | ||||
| KOHINOOR | Kohinoor Foods | 1.14 | ||||
| RATNAMANI | Ratnamani Metals | 1.26 | ||||
| MANAKCOAT | Manaksia Coated | 2.00 | ||||
| VBL | Varun Beverages | 2.06 |
Complementary Tools for NBIFIN Stock analysis
When running N B's price analysis, check to measure N B's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy N B is operating at the current time. Most of N B's value examination focuses on studying past and present price action to predict the probability of N B's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move N B's price. Additionally, you may evaluate how the addition of N B to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |